{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:16:28Z","timestamp":1787505388989,"version":"build-2736575974"},"update-to":[{"DOI":"10.12688\/hrbopenres.13501.1","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T00:00:00Z","timestamp":1660867200000}}],"reference-count":46,"publisher":"F1000 Research Ltd","license":[{"start":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T00:00:00Z","timestamp":1660867200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010414","name":"Health Research Board","doi-asserted-by":"publisher","award":["LP-HSR-2019-012"],"award-info":[{"award-number":["LP-HSR-2019-012"]}],"id":[{"id":"10.13039\/100010414","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001637","name":"Trinity College Dublin","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001637","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["hrbopenresearch.org"],"crossmark-restriction":false},"short-container-title":["HRB Open Res"],"abstract":"<ns4:p>\n                    <ns4:bold>Background<\/ns4:bold>\n                    : In the context of a recovery-oriented approach to mental healthcare, the role of psychotropic medication over extended or indefinite periods is increasingly being called into question. To minimise the risks of withdrawal symptoms and relapse, it is crucial that service users who want to discontinue psychotropic medication are supported throughout the tapering process. However, in the absence of effective interventions and supports, service users are increasingly relying on online resources for guidance and support. To date, the evidence base for mobile phone applications (\u2018apps\u2019) and app-based interventions supporting discontinuation of psychotropic use has not been examined. This scoping review aims to examine the content, underpinning evidence base and impact of available mobile phone apps and app-based interventions to support psychotropic tapering.\n                  <\/ns4:p>\n                  <ns4:p\/>\n                  <ns4:p>\n                    <ns4:bold>Methods<\/ns4:bold>\n                    <ns4:bold>:<\/ns4:bold>\n                    A scoping review will be conducted using the Joanna Briggs Institute guidance and results will be reported using the Preferred Reporting Items for Systematic Reviews and Meta\u2010Analyses extension for Scoping Reviews (PRISMA-ScR) guideline. Several electronic databases (MEDLINE, EMBASE, CINAHL, PsycINFO, Web of Science, ACM and IEEE Xplore) will be searched from 2008 onwards. Searches of the major app stores will also be conducted, specifically Apple's App Store (iOS) and Google Play Store (Android). Following screening, key information will be extracted from the included studies and apps. Identified apps will be coded using the Behaviour Change Technique (BCT) Taxonomy. The findings will be described using narrative synthesis.\n                  <\/ns4:p>\n                  <ns4:p\/>\n                  <ns4:p>\n                    <ns4:bold>Conclusions<\/ns4:bold>\n                    <ns4:bold>:<\/ns4:bold>\n                    This scoping review will provide a broad overview of available apps to support psychotropic tapering, including a summary of their content using the BCT Taxonomy. The review findings will guide future research relating to the development, implementation and evaluation of app-based interventions to support the tapering of psychotropic medication.\n                  <\/ns4:p>","DOI":"10.12688\/hrbopenres.13501.2","type":"journal-article","created":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T10:05:08Z","timestamp":1660903508000},"page":"18","update-policy":"https:\/\/doi.org\/10.12688\/hrbopenres.crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Mobile phone applications to support psychotropic tapering: a scoping review protocol"],"prefix":"10.12688","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0865-2794","authenticated-orcid":false,"given":"Miriam","family":"Boland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0631-1884","authenticated-orcid":false,"given":"Agnes","family":"Higgins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin","family":"Doherty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg","family":"Sheaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4094-6744","authenticated-orcid":false,"given":"Adele","family":"Framer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8778-0112","authenticated-orcid":false,"given":"Cathal","family":"Cadogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2560","published-online":{"date-parts":[[2022,8,19]]},"reference":[{"key":"ref-1","doi-asserted-by":"publisher","first-page":"l1508","DOI":"10.1136\/bmj.l1508","article-title":"NHS prescribed record number of antidepressants last year.","volume":"364","author":"G Iacobucci","year":"2019","journal-title":"BMJ."},{"key":"ref-2","doi-asserted-by":"publisher","first-page":"2045125320981174","DOI":"10.1177\/2045125320981174","article-title":"The role of Facebook groups in the management and raising of awareness of antidepressant withdrawal: is social media filling the void left by health services?","volume":"11","author":"E White","year":"2021","journal-title":"Ther Adv Psychopharmacol."},{"key":"ref-3","doi-asserted-by":"publisher","first-page":"1071-82","DOI":"10.1016\/S2215-0366(21)00292-3","article-title":"Psychotropic medicine consumption in 65 countries and regions, 2008-19: a longitudinal study.","volume":"8","author":"R Brauer","year":"2021","journal-title":"Lancet Psychiatry."},{"key":"ref-4","doi-asserted-by":"publisher","first-page":"47-53","DOI":"10.1001\/jama.2009.1943","article-title":"Antidepressant drug effects and depression severity: a patient-level meta-analysis.","volume":"303","author":"J Fournier","year":"2010","journal-title":"JAMA."},{"key":"ref-5","doi-asserted-by":"publisher","first-page":"23-33","DOI":"10.1111\/bcp.14475","article-title":"Strategies to reduce use of antidepressants.","volume":"87","author":"T Kendrick","year":"2021","journal-title":"Br J Clin Pharmacol."},{"key":"ref-6","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1136\/bmjebm-2019-111238","article-title":"Should antidepressants be used for major depressive disorder?","volume":"25","author":"J Jakobsen","year":"2020","journal-title":"BMJ Evid Based Med."},{"key":"ref-7","first-page":"105-9","article-title":"Cross-sectional survey of patients in receipt of long-term repeat prescriptions for antidepressant drugs in primary care.","volume":"5","author":"G Cruickshank","year":"2008","journal-title":"Ment Health Fam Med."},{"key":"ref-8","doi-asserted-by":"publisher","first-page":"367-81","DOI":"10.1177\/0004867419898761","article-title":"Antidepressant treatment for primary care patients with depressive symptoms: Data from the diamond longitudinal cohort study.","volume":"54","author":"S Davidson","year":"2020","journal-title":"Aust N Z J Psychiatry."},{"key":"ref-9","doi-asserted-by":"publisher","first-page":"361-5","DOI":"10.1192\/bjp.bp.116.182683","article-title":"Should psychiatrists be more cautious about the long-term prophylactic use of antipsychotics?","volume":"209","author":"R Murray","year":"2016","journal-title":"Br J Psychiatry."},{"key":"ref-10","doi-asserted-by":"publisher","first-page":"1354-63","DOI":"10.1111\/bcp.13570","article-title":"Benzodiazepine and Z\u2010drug prescribing in Ireland: analysis of national prescribing trends from 2005 to 2015.","volume":"84","author":"C Cadogan","year":"2018","journal-title":"Br J Clin Pharmacol."},{"key":"ref-11","doi-asserted-by":"publisher","first-page":"1037-47","DOI":"10.1016\/j.eurpsy.2015.09.003","article-title":"Long-term use of benzodiazepines: Definitions, prevalence and usage patterns \u2013 a systematic review of register-based studies.","volume":"30","author":"T Kurko","year":"2015","journal-title":"Eur Psychiatry."},{"key":"ref-12","doi-asserted-by":"publisher","first-page":"100098","DOI":"10.1016\/j.ssmmh.2022.100098","article-title":"Is the chemical imbalance an \u2018urban legend\u2019? An exploration of the status of the serotonin theory of depression in the scientific literature.","volume":"2","author":"B Ang","year":"2022","journal-title":"SSM - Mental Health."},{"key":"ref-13","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-022-01661-0","article-title":"The serotonin theory of depression: a systematic umbrella review of the evidence.","author":"J Moncrieff","year":"2022","journal-title":"Mol Psychiatry."},{"key":"ref-14","article-title":"National framework for recovery in mental health: A national framework for mental health service providers to support the delivery of a quality person-centred service (2018-2020)","year":"2018"},{"key":"ref-15","doi-asserted-by":"publisher","first-page":"270-85","DOI":"10.1111\/inm.12241","article-title":"\"What is the work of Recovery Oriented Practice? A systematic literature review\".","volume":"25","author":"P Chester","year":"2016","journal-title":"Int J Ment Health Nurs."},{"key":"ref-16","doi-asserted-by":"publisher","first-page":"155-63","DOI":"10.1016\/j.nedt.2015.11.015","article-title":"From the rhetoric to the real: A critical review of how the concepts of recovery and social inclusion may inform mental health nurse advanced level curricula \u2014 The eMenthe project.","volume":"37","author":"T Stickley","year":"2016","journal-title":"Nurse Educ Today."},{"key":"ref-17","doi-asserted-by":"publisher","DOI":"10.13140\/RG.2.2.28150.34887","article-title":"My voice matters: Report on a national consultation with mental health service user.","author":"P \u00d3 F\u00e9ich","year":"2019"},{"key":"ref-18","doi-asserted-by":"publisher","first-page":"513-23","DOI":"10.1080\/09638237.2019.1581352","article-title":"Antipsychotic treatment \u2013 a systematic literature review and meta-analysis of qualitative studies.","volume":"29","author":"J Bjornestad","year":"2020","journal-title":"J Ment Health."},{"key":"ref-19","article-title":"Report of the Special Rapporteur on the Right of Everyone to the Enjoyment of the Highest Attainable Standard of Physical and Mental Health: note.","author":"D Puras","year":"2017"},{"key":"ref-20","doi-asserted-by":"publisher","first-page":"389-96","DOI":"10.1177\/0897190012467210","article-title":"Guidance for the discontinuation or switching of antidepressant therapies in adults.","volume":"26","author":"N Ogle","year":"2013","journal-title":"J Pharm Pract."},{"key":"ref-21","doi-asserted-by":"publisher","first-page":"1257-67","DOI":"10.1056\/NEJMoa2106356","article-title":"Maintenance or Discontinuation of Antidepressants in Primary Care.","volume":"385","author":"G Lewis","year":"2021","journal-title":"N Engl J Med."},{"key":"ref-22","doi-asserted-by":"publisher","first-page":"1-12","DOI":"10.1080\/09638237.2021.1922644","article-title":"Mental health service users experiences of medication discontinuation: a systematic review of qualitative studies.","author":"B Keogh","year":"2021","journal-title":"J Ment Health."},{"key":"ref-23","doi-asserted-by":"publisher","first-page":"1395-406","DOI":"10.1111\/inm.12894","article-title":"Deciding to discontinue prescribed psychotropic medication: A qualitative study of service users' experiences.","volume":"30 Suppl 1","author":"M Watts","year":"2021","journal-title":"Int J Ment Health Nurs."},{"key":"ref-24","doi-asserted-by":"publisher","first-page":"Cd013495","DOI":"10.1002\/14651858.CD013495.pub2","article-title":"Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults.","volume":"4","author":"E Van Leeuwen","year":"2021","journal-title":"Cochrane Database Syst Rev."},{"key":"ref-25","doi-asserted-by":"publisher","first-page":"1618-39","DOI":"10.1111\/add.14981","article-title":"Brief interventions targeting long-term benzodiazepine and Z-drug use in primary care: a systematic review and meta-analysis.","volume":"115","author":"T Lynch","year":"2020","journal-title":"Addiction."},{"key":"ref-26","doi-asserted-by":"publisher","first-page":"Cd009652","DOI":"10.1002\/14651858.CD009652.pub2","article-title":"Psychosocial interventions for benzodiazepine harmful use, abuse or dependence.","author":"C Darker","year":"2015","journal-title":"Cochrane Database Syst Rev."},{"key":"ref-27","doi-asserted-by":"publisher","first-page":"2045125321991274","DOI":"10.1177\/2045125321991274","article-title":"What I have learnt from helping thousands of people taper off antidepressants and other psychotropic medications.","volume":"11","author":"A Framer","year":"2021","journal-title":"Ther Adv Psychopharmacol."},{"key":"ref-28","doi-asserted-by":"publisher","first-page":"1116-1129","DOI":"10.1093\/schbul\/sbab017","article-title":"A method for tapering antipsychotic treatment that may minimize the risk of relapse.","volume":"47","author":"M Horowitz","year":"2021","journal-title":"Schizophr Bull."},{"key":"ref-29","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s11920-015-0642-5","article-title":"Withdrawing Benzodiazepines in Patients With Anxiety Disorders.","volume":"18","author":"M Lader","year":"2016","journal-title":"Curr Psychiatry Rep."},{"key":"ref-30","doi-asserted-by":"publisher","first-page":"324-8","DOI":"10.1124\/jpet.111.183285","article-title":"Drug discontinuation effects are part of the pharmacology of a drug.","volume":"339","author":"M Reidenberg","year":"2011","journal-title":"J Pharmacol Exp Ther."},{"key":"ref-31","doi-asserted-by":"publisher","first-page":"2045125320967183","DOI":"10.1177\/2045125320967183","article-title":"The 'patient voice': patients who experience antidepressant withdrawal symptoms are often dismissed, or misdiagnosed with relapse, or a new medical condition.","volume":"10","author":"A Guy","year":"2020","journal-title":"Ther Adv Psychopharmacol."},{"key":"ref-32","doi-asserted-by":"publisher","first-page":"111-21","DOI":"10.1016\/j.addbeh.2018.08.027","article-title":"A systematic review into the incidence, severity and duration of antidepressant withdrawal effects: Are guidelines evidence-based?","volume":"97","author":"J Davies","year":"2019","journal-title":"Addict Behav."},{"key":"ref-33","doi-asserted-by":"publisher","first-page":"e52","DOI":"10.1017\/S2045796019000465","article-title":"Antidepressant withdrawal \u2013 the tide is finally turning.","volume":"29","author":"M Hengartner","year":"2020","journal-title":"Epidemiol Psychiatr Sci."},{"key":"ref-34","doi-asserted-by":"publisher","first-page":"106157","DOI":"10.1016\/j.addbeh.2019.106157","article-title":"How common and severe are six withdrawal effects from, and addiction to, antidepressants? The experiences of a large international sample of patients.","volume":"102","author":"J Read","year":"2020","journal-title":"Addict Behav."},{"key":"ref-35","doi-asserted-by":"publisher","first-page":"113-22","DOI":"10.1017\/S2045796015001067","article-title":"The future of mental health care: peer-to-peer support and social media.","volume":"25","author":"J Naslund","year":"2016","journal-title":"Epidemiol Psychiatr Sci."},{"key":"ref-36","doi-asserted-by":"publisher","first-page":"198-204","DOI":"10.1016\/j.euf.2020.02.002","article-title":"A Content Analysis of Mobile Phone Applications for the Diagnosis, Treatment, and Prevention of Urinary Tract Infections, and Their Compliance with European Association of Urology Guidelines on Urological Infections.","volume":"7","author":"S Vaggers","year":"2021","journal-title":"Eur Urol Focus."},{"key":"ref-37","doi-asserted-by":"publisher","first-page":"2042-66","DOI":"10.1177\/1460458219896492","article-title":"Insights from user reviews to improve mental health apps.","volume":"26","author":"F Alqahtani","year":"2020","journal-title":"Health Informatics J."},{"key":"ref-38","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.3389\/fpsyg.2017.01769","article-title":"Smartphone Applications for Educating and Helping Non-motivating Patients Adhere to Medication That Treats Mental Health Conditions: Aims and Functioning.","volume":"8","author":"A Kassianos","year":"2017","journal-title":"Front Psychol."},{"key":"ref-39","doi-asserted-by":"publisher","first-page":"81-95","DOI":"10.1007\/s12160-013-9486-6","article-title":"The Behavior Change Technique Taxonomy (v1) of 93 Hierarchically Clustered Techniques: Building an International Consensus for the Reporting of Behavior Change Interventions.","volume":"46","author":"S Michie","year":"2013","journal-title":"Ann Behav Med."},{"key":"ref-40","doi-asserted-by":"publisher","first-page":"2119-2126","DOI":"10.11124\/JBIES-20-00167","article-title":"Updated methodological guidance for the conduct of scoping reviews.","volume":"18","author":"M Peters","year":"2020","journal-title":"JBI Evid Synth."},{"key":"ref-41","doi-asserted-by":"crossref","DOI":"10.46658\/JBIMES-20-01","article-title":"JBI Manual for Evidence Synthesis.","author":"E Aromataris","year":"2020;"},{"key":"ref-42","doi-asserted-by":"publisher","first-page":"467-73","DOI":"10.7326\/M18-0850","article-title":"PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation.","volume":"169","author":"A Tricco","year":"2018","journal-title":"Ann Intern Med."},{"key":"ref-43","article-title":"A Scoping Review of Mobile Phone Applications to Support Psychotropic Tapering (protocol).","author":"M Boland","year":"2022"},{"key":"ref-44","doi-asserted-by":"publisher","first-page":"l6890","DOI":"10.1136\/bmj.l6890","article-title":"Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline.","volume":"368","author":"M Campbell","year":"2020","journal-title":"BMJ."},{"key":"ref-45","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13012-015-0248-7","article-title":"Using a behaviour change techniques taxonomy to identify active ingredients within trials of implementation interventions for diabetes care.","volume":"10","author":"J Presseau","year":"2015","journal-title":"Imp Sci."},{"key":"ref-46","doi-asserted-by":"publisher","DOI":"10.46658\/JBIMES-20-08","article-title":"Chapter 7: Systematic reviews of etiology and risk.","author":"S Moola","year":"2020","journal-title":"JBI Manual for Evidence Synthesis."}],"container-title":["HRB Open Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/hrbopenresearch.org\/articles\/5-18\/v2\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/hrbopenresearch.org\/articles\/5-18\/v2\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/hrbopenresearch.org\/articles\/5-18\/v2\/iparadigms","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,4]],"date-time":"2022-10-04T11:40:10Z","timestamp":1664883610000},"score":1,"resource":{"primary":{"URL":"https:\/\/hrbopenresearch.org\/articles\/5-18\/v2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,19]]},"references-count":46,"URL":"https:\/\/doi.org\/10.12688\/hrbopenres.13501.2","relation":{"has-review":[{"id-type":"doi","id":"10.21956\/hrbopenres.14874.r32714","asserted-by":"subject"},{"id-type":"doi","id":"10.21956\/hrbopenres.14874.r32714","asserted-by":"object"}]},"ISSN":["2515-4826"],"issn-type":[{"value":"2515-4826","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,19]]},"assertion":[{"value":"Indexed","URL":"https:\/\/hrbopenresearch.org\/articles\/5-18\/v2#article-reports","order":0,"name":"referee-status","label":"Referee status","group":{"name":"current-referee-status","label":"Current Referee Status"}},{"value":"10.21956\/hrbopenres.14874.r32714, Mark Horowitz, Division of Psychiatry, University College London, London, UK, 04 Oct 2022, version 2, indexed","URL":"https:\/\/hrbopenresearch.org\/articles\/5-18\/v2#referee-response-32714","order":0,"name":"referee-response-32714","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"10.21956\/hrbopenres.14726.r32384, Luke Molloy, School of Nursing, University of Wollongong, Wollongong, NSW, Australia, 29 Jul 2022, version 1, 1 approved, 1 approved with reservations","URL":"https:\/\/hrbopenresearch.org\/articles\/5-18\/v1#referee-response-32384","order":1,"name":"referee-response-32384","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"<b>Miriam Boland<\/b>; \n<i>Posted: 16 Aug 2022<\/i>; There is a clear rationale for this proposed review. The area is of interest to mental health-related clinicians and academics, and I am sure there will be interest in its findings across disciplines. There is a clear narrative and excellent use of literature within the sections establishing this. A scoping review is established as the most appropriate approach to understanding this phenomenon, and the details of the methods are clear and would allow replication of the work to be undertaken. The findings of such a work will support quality recovery-focused mental health care.  \n<b><u>Response:<\/u><\/b> We are very grateful to the reviewer for reviewing our manuscript and for the positive feedback they have provided.","URL":"https:\/\/hrbopenresearch.org\/articles\/5-18\/v2#referee-comment-3485","order":2,"name":"referee-comment-3485","label":"Referee Comment","group":{"name":"article-reports","label":"Article Reports"}},{"value":"Health Research Board Ireland [LP-HSR-2019-012]. Miriam Boland was supported by a 1252 Scholarship from the School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","order":3,"name":"grant-information","label":"Grant Information"},{"value":"This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.","order":0,"name":"copyright-info","label":"Copyright"}]}}